Position in NVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$32,397,471
+$1,382,348 QoQ
Shares Held
206,722
+1.8% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#82
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cetera Investment Advisers holds $1,560,895,629 across 16 Drug Manufacturers - General names. NVS ranks #10 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
366,026 | $439,022,601 | |
| 2 | JNJ |
Johnson & Johnson
|
1,094,399 | $277,944,514 | |
| 3 | ABBV |
AbbVie Inc.
|
990,692 | $249,297,734 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,229,081 | $157,936,908 | |
| 5 | AMGN |
Amgen Inc
|
333,544 | $120,782,953 | |
| 6 | PFE |
Pfizer Inc
|
3,183,708 | $76,663,688 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
413,202 | $52,203,940 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
883,910 | $50,930,894 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,397,471 | 206,722 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $31,015,123 | 203,045 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $24,671,698 | 178,949 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $23,061,014 | 179,827 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $17,820,053 | 147,261 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $14,105,341 | 126,528 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $12,244,614 | 125,831 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $13,099,052 | 113,885 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $11,673,977 | 109,656 | Shares | Sole | 2024-08-22 | |
| 2024-03-31 | $10,305,130 | 106,535 | Shares | Sole | 2024-05-24 | |
| 2023-12-31 | $2,196,905 | 21,758 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,330,454 | 22,879 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,198,324 | 21,785 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,713,500 | 18,625 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,761,963 | 19,422 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $754,323 | 9,924 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,412,073 | 16,705 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,394,698 | 15,894 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,441,155 | 16,476 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,366,462 | 16,709 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,600,805 | 17,545 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,445,979 | 16,916 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,754,603 | 18,581 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $220,530 | 2,536 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $243,241 | 2,785 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $233,663 | 2,834 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||